Variables | HR | 95% CI | p |
---|---|---|---|
ECOG PS | Â | Â | 0.008 |
 0–1 | 1.00 |  |  |
 2 | 1.744 | 1.158–2.626 |  |
T stage | Â | Â | 0.028 |
 T1–T2 | 1.00 |  |  |
 T3–T4 | 1.332 | 1.032–1.718 |  |
N stage | Â | Â | 0.018 |
 Negative | 1.00 |  |  |
 Positive | 1.848 | 1.113–3.068 |  |
Clinical stage | Â | Â | 0.653 |
 III A | 1.00 |  |  |
 III B | 1.058 | 0.828–1.350 |  |
SII | Â | Â | <Â 0.001 |
 < 660 | 1.00 |  |  |
 ≥ 660 | 2.105 | 1.481–2.741 |  |
NLR | Â | Â | <Â 0.001 |
 < 3.57 | 1.00 |  |  |
 ≥ 3.57 | 1.934 | 1.448–2.585 |  |
PLR | Â | Â | 0.083 |
 < 147 | 1.00 |  |  |
 ≥ 147 | 1.299 | 0.966–1.748 |  |
PNI | Â | Â | 0.131 |
 ≥ 52.95 | 1.00 |  |  |
 < 52.95 | 1.263 | 0.933–1.709 |  |